Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

CAMP - Camp4 Therapeutics Corporation... | Finranks

Home

/

CAMP

C

Camp4 Therapeutics Corporation (CAMP)

NGM – Real Time Price. Currency in USD

4.52

+0.35 (8.39%)

Market open: Aug 12, 2026, 12:53 PM EDT

4.44

+0.27 (6.47%)

Previous after-hours: Aug 11, 2026, 5:50 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

3M

652K

350K

0

Cost of goods sold

-2M

-2M

-2M

-947K

Gross Profit

2M

-1M

-1M

-947K

Operating expenses (excl. COGS)

-54M

-52M

-50M

-44M

Operating Income

-52M

-53M

-52M

-45M

Non-operating income, total

-28M

1M

3M

809K

Pretax income

-80M

-52M

-49M

-44M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-80M

-52M

-49M

-44M

Discontinued operations

0

0

0

0

Net income

-80M

-52M

-49M

-44M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

118M+50.4%

78M+42.5%

55M-46.4%

103M

Total current assets

114M

66M

40M

84M

Total non-current assets

4M

12M

15M

18M

Total liabilities

70M+362.3%

15M-8.3%

17M-8.0%

18M

Total current liabilities

16M

10M

8M

8M

Total non-current liabilities

55M

6M

9M

10M

Total equity

48M

63M

38M

85M

Total liabilities & shareholders' equities

118M

78M

55M

103M

Total debt

2M-77.4%

9M-28.3%

12M-1.7%

12M

Name

2025

2024

2023

2022

Cash from operating activities

-30M

-50M

-44M

-39M

Cash from investing activities

-243K

-441K

-678K

-4M

Cash from financing activities

76M

76M

301K

100M

Free cash flow

-30M+40.3%

-50M-11.5%

-45M-5.3%

-43M